PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular, a leader in membrane protein antibody discovery, announced today the appointment of DNA immunization expert Ross Chambers, Ph.D., as Director of Antibody Discovery.
Dr. Chambers will lead the company’s rapidly expanding Antibody Discovery business, which includes its proprietary MPS Discovery Engine® platform that delivers high performance monoclonal antibodies (MAbs) against difficult membrane protein targets. MPS includes target engineering, MAb discovery, antibody engineering, and characterization through animal proof of concept.
Dr. Chambers will lead the company’s rapidly expanding Antibody Discovery business, which includes its proprietary MPS Discovery Engine® platform that delivers high performance monoclonal antibodies (MAbs) against difficult membrane protein targets. MPS includes target engineering, MAb discovery, antibody engineering, and characterization through animal proof of concept.
